These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 17035374)

  • 21. Hyperaluminemia associated with liver transplantation and acute renal failure.
    Erasmus RT; Kusnir J; Stevenson WC; Lobo P; Herman MM; Wills MR; Savory J
    Clin Transplant; 1995 Aug; 9(4):307-11. PubMed ID: 7579738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aluminium in bone from patients with renal failure.
    Parsons V; Davies C; Goode C; Ogg C; Siddiqui J
    Br Med J; 1971 Oct; 4(5782):273-5. PubMed ID: 5123910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality of water used for haemodialysis: bacterial and chemical parameters. I. Vorbeck-Meister et al. Nephrology, Dialysis and Transplantation, 1999 14 666-675.
    EDTNA ERCA J; 1999; 25(4):24-5. PubMed ID: 10827594
    [No Abstract]   [Full Text] [Related]  

  • 24. Calcium balance during hemodialysis.
    McIntyre CW
    Semin Dial; 2008; 21(1):38-42. PubMed ID: 18251956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Dialysis encephalopathy in chronic renal failure].
    Markiewicz K; Bubiński R
    Pol Tyg Lek; 1980 Jul; 35(30):1159-62. PubMed ID: 7001402
    [No Abstract]   [Full Text] [Related]  

  • 26. [Aluminium accumulation in patients with chronic renal failure (author's transl)].
    Tsukamoto Y; Marumo F; Iwanami S; Nango H; Higashishiba H; Nakazawa R
    Nihon Jinzo Gakkai Shi; 1980 Jun; 22(6):721-8. PubMed ID: 7206332
    [No Abstract]   [Full Text] [Related]  

  • 27. Does hyperprolactinaemia predispose to aluminium toxicity in chronic renal failure?
    Garrett PJ
    Nephrol Dial Transplant; 1994; 9(11):1695. PubMed ID: 7870367
    [No Abstract]   [Full Text] [Related]  

  • 28. Aluminum toxicity in patients with chronic renal failure.
    Alfrey AC
    Ther Drug Monit; 1993 Dec; 15(6):593-7. PubMed ID: 8122300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How long is the warranty period for nil or low coronary artery calcium in patients new to hemodialysis?
    Bellasi A; Kooienga L; Block GA; Veledar E; Spiegel DM; Raggi P
    J Nephrol; 2009; 22(2):255-62. PubMed ID: 19384844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo studies with a non-aluminum phosphate-binding compound.
    Schneider HW; Kulbe KD; Weber H; Streicher E
    Kidney Int Suppl; 1986 Feb; 18():S120-3. PubMed ID: 3457989
    [No Abstract]   [Full Text] [Related]  

  • 32. Recurrent flushing in a hemodialysis patient.
    Georgiadou F; Moutzouris DA; Kassimatis TI; Charitaki E; Christodoulidou C; Margelos V; Hadjiconstantinou V
    Semin Dial; 2006; 19(6):558-9. PubMed ID: 17150061
    [No Abstract]   [Full Text] [Related]  

  • 33. Dialysate calcium and the European best practice guidelines on hemodynamic instability.
    Kooman JP; Basci A; Pizzarelli F; Vanholder R;
    Semin Dial; 2009; 22(3):311. PubMed ID: 19573013
    [No Abstract]   [Full Text] [Related]  

  • 34. Unusual dialysate leakage complicating peritoneal dialysis.
    Chiu JS; Wang YF
    J Assoc Physicians India; 2006 Apr; 54():290. PubMed ID: 16944612
    [No Abstract]   [Full Text] [Related]  

  • 35. Diagnostic and therapeutic approaches to aluminium overload in dialysed patients--representative study by questionnaire in West German dialysis units in 1989-1990.
    Hümpfner A; Hummel S; Schulz W
    Nephrol Dial Transplant; 1993; 8 Suppl 1():51-4. PubMed ID: 8389023
    [No Abstract]   [Full Text] [Related]  

  • 36. Changes in bone histoquantitative parameters and histochemical staining reactions for aluminium in a group of patients with chronic renal failure following a reduction in the aluminium concentration of the haemodialysis fluid.
    McClure J; Fazzalari NL; Fassett RG; Pugsley PG
    J Clin Pathol; 1984 Jul; 37(7):743-7. PubMed ID: 6747011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucotoxicity in peritoneal dialysis--solutions for the solution!
    Holmes CJ
    Adv Chronic Kidney Dis; 2007 Jul; 14(3):269-78. PubMed ID: 17603981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ET-AAS determination of aluminium in dialysis concentrates after continuous flow solvent extraction.
    Komárek J; Cervenka R; Růzicka T; Kubán V
    J Pharm Biomed Anal; 2007 Nov; 45(3):504-9. PubMed ID: 17897803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aluminum exposure in chronic renal failure in iberoamerica at the end of the 1990s: overview and perspectives.
    Fernández-Martín JL; Canteros A; Alles A; Massari P; Cannata-Andía J
    Am J Med Sci; 2000 Aug; 320(2):96-9. PubMed ID: 10981483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of dialytic modalities on clinical outcomes in ESRD patients with familial Mediterranean fever.
    Sahin S; Sahin GM; Ergin H; Kantarci G
    Ren Fail; 2007; 29(3):315-9. PubMed ID: 17497446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.